CNS Remission Achieved With Brexu-Cel in Relapsed/Refractory B-ALL
Brexu-cel showed efficacy in eliciting both CNS and systemic responses in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Source: onclive.com
Mlb All News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mlb All. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mlb All Today - Breaking & Trending Today
No God, Church, Temple Or Mosque Would Approve Malpractices By Priest/Godmen For Religious Conversion: Allahabad HC Denies Relief To SHUATS Officials
Refusing to quash an FIR lodged against the Vice Chancellor and other higher officials of the Sam Higginbottom University of Agriculture Technology and Science (SHUATS) accused of persuading a woman...
Source: livelaw.in
Obe-Cel Elicits High Remission Rates in R/R B-ALL Irrespective of Leukemic Burden
Obecabtagene autoleucel elicited durable responses in patients with relapsed or refractory B-cell acute lymphoblastic leukemia independent of leukemic burden at lymphodepletion, although better outcomes were observed in those with lower burden.
Source: onclive.com
DNA Index Most Effectively Identifies Patients With Hyperdiploid ALL
The measure of total DNA in leukemic cells as defined by a DNA index outperformed other criteria for identifying patients with hyperdiploid acute lymphoblastic leukemia (ALL) and favorable prognosis.
Source: ajmc.com
The Future of R/R B-ALL Treatment
Jae Park, MD, wraps up his discussion by highlighting exciting investigational agents on the horizon for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.
Source: onclive.com